Oral Contraception vs Insulin Sensitization for 18 Months in Nonobese Adolescents With Androgen Excess: Posttreatment Differences in C-Reactive Protein, Intima-Media Thickness, Visceral Adiposity, Insulin Sensitivity, and Menstrual Regularity-Reference-Cited by-同舟云学术

Oral Contraception vs Insulin Sensitization for 18 Months in Nonobese Adolescents With Androgen Excess: Posttreatment Differences in C-Reactive Protein, Intima-Media Thickness, Visceral Adiposity, Insulin Sensitivity, and Menstrual Regularity

Published:2013-05-01 Issue:5 Volume:98 Page:E902-E907
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Ibáñez Lourdes¹²,Díaz Marta¹²,Sebastiani Giorgia¹²,Marcos María Victoria²³,López-Bermejo Abel⁴,de Zegher Francis⁵

Affiliation:

1. Endocrinology Unit (L.I., M.D., G.S.), Hospital Sant Joan de Déu, University of Barcelona, 08950 Esplugues, Barcelona, Spain;

2. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (L.I., M.D., G.S., M.V.M.), Instituto de Salud Carlos III, 28029 Madrid, Spain;

3. Endocrinology Unit (M.V.M.), Hospital de Terrassa, Barcelona, Spain;

4. Department of Pediatrics (A.L.), Dr. Josep Trueta Hospital and Girona Institute for Biomedical Research, 17007 Girona, Spain;

5. University of Leuven (F.d.Z.), 3000 Leuven, Belgium

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/98/5/E902/9049167/jcemE902.pdf

Reference25 articles.

1. Clinical variability in approaches to polycystic ovary syndrome;Bonny;J Pediatr Adolesc Gynecol,2012

2. Polycystic ovary syndrome;Norman;Lancet,2007

3. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy;Franks;Hum Reprod,2008

4. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome;Luque-Ramírez;J Clin Endocrinol Metab,2007

5. Hyperandrogenism in adolescent girls;Catteau-Jonard;Endocr Dev,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor from de Zegher and Ibáñez: “Adipose Tissue Dysfunction in Polycystic Ovary Syndrome”;The Journal of Clinical Endocrinology & Metabolism;2024-06-26

2. Response to Letter to the Editor From de Zegher and Ibáñez: “Adipose Tissue Dysfunction in Polycystic Ovary Syndrome”;The Journal of Clinical Endocrinology & Metabolism;2024-06-26

3. Subdermal Progestin Implant and an Oral Combined Hormonal Contraceptive in Youth with Type 1 Diabetes;Journal of Pediatric and Adolescent Gynecology;2023-11

4. SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial;Trials;2023-09-15

5. Sex-Specific Features of the Correlation between GWAS-Noticeable Polymorphisms and Hypertension in Europeans of Russia;International Journal of Molecular Sciences;2023-04-25